News

Moderna in the News

2014

World Economic Forum, April 1, 2014: Interview with Noubar Afeyan: A new weapon in the fight against cancer

Harvard Business School, January 31, 2014: Body, Heal Thyself: Stéphane Bancel has taken Moderna Therapeutics from a one-man shop to a company that's poised to revolutionize the biotech world

Xconomy, January 14, 2014: Moderna Spins Out mRNA Cancer Drugs Into New Company, Onkaido

Genetic Engineering & Biotechnology News, January 14, 2014: Flush with Cash, Moderna Launches New Oncology-Focused Venture

Xconomy, January 13, 2014: Moderna, Living a Charmed Life, Pulls in Another $125M From Alexion

Genetic Engineering & Biotechnology News, January 13, 2014: Alexion, Moderna to Develop Rare Disease-Fighting mRNA Therapeutics

Boston.com, January 13, 2014: Alexion, Moderna Announce Agreement to Develop Messenger RNA Therapeutics

 

2013

BusinessWire, November 21, 2013: Syros Pharmaceuticals Appoints Stéphane Bancel to Board of Directors

Dow Jones, November 20, 2013: Staying Private, Moderna Raises $110M for Messenger RNA Therapeutics

Xconomy, November 20, 2013: Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs

FierceBiotech, November 20, 2013: Moderna nails $110M to get mRNA tech into the clinic

Xconomy, October 2, 2013: Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs

FierceBiotech, September 24, 2013: Moderna Therapeutics Wins Fierce 15 Biotech Award

Bloomberg, March 28, 2013: AstraZeneca CEO Chases Multiple Strands in RNA Drug Quest

Xconomy, March 21, 2013: AstraZeneca Shells Out $240 Upfront For Moderna mRNA Drugs

New York Times, March 21, 2013: AstraZeneca to Pay $240 Million to Moderna Therapeutics

Boston Magazine, February 26, 2013: Does Moderna Therapeutics Have the Next Big Thing in Biotech?

 

2012

Xconomy, December 6, 2012: Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug”

Press Releases

2014

March 6, 2014: Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer

February 19, 2014: Massachusetts Life Sciences Center Awards Tax Incentives to 33 Companies Center Awards $25 million to foster job growth in the Massachusetts Life Sciences sectors

January 14, 2014: Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA Therapeutics™ in Oncology with $20 Million Capital Commitment

January 13, 2014: Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics™ for Rare Diseases

January 6, 2014: Moderna Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference

 

2013

December 17, 2013: Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors

November 20, 2013: Moderna Closes New Financing Round Raising $110M to Develop Messenger RNA Therapeutics™

October 24, 2013: Moderna Therapeutics Named to the World Economic Forum's Community of "Global Growth Companies"

October 17, 2013: Moderna Therapeutics Announces Expansion to New Headquarters and Laboratories at 200 Tech Square

October 2, 2013: DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™

September 24, 2013: Moderna Therapeutics Named a “Fierce 15” Biotech Company for 2013.

September 8, 2013: Study Published in Nature Biotechnology Demonstrates Ability of Moderna’s Novel Therapeutic Paradigm to Repair and Regenerate Damaged Heart Tissue

July 31, 2013: Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development

May 22, 2013: Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer

April 30, 2013: Henri A. Termeer Joins Moderna Therapeutics Board of Directors

March 21, 2013: AstraZeneca and Moderna Therapeutics Announce Exclusive Agreement to Develop Pioneering Messenger RNA Therapeutics™ in Cardiometabolic Diseases and Cancer

February 27, 2013: Massachusetts Life Sciences Center Awards Tax Incentives to 25 Companies

January 16, 2013: Moderna Appoints Divakar Ramamakishnan, Ph.D., as Senior Vice President of Process Development, Manufacturing and Quality

 

2012

December 19, 2012: Moderna Appoints Stephen Hoge as Senior Vice President of Corporate Development and New Drug Concepts

December 6, 2012: Moderna Announces $40 Million in Financing to Advance Development of New Biotherapeutic Modality: Messenger RNA Therapeutics™

February 22, 2012: Massachusetts Life Sciences Center Announces Tax Incentives Targeting Growth at 28 Companies Center Awards $21.2 million to foster job growth in the Massachusetts Life Sciences sectors

 

2010

December 9, 2010: Flagship VentureLabs Company ModeRNA Therapeutics, and co-founder, Derrick Rossi, both Cited by Time Magazine for Significant Advances and Contributions in 2010

September 30, 2010: Flagship VentureLabs company, ModeRNA Therapeutics, Announces Safe and Efficient Method for Creating and Differentiating Human Pluripotent Stem Cells

 

 

Stay Connected

Join the Moderna Therapeutics mailing list.